Editorial: What Is Reasonable and Necessary for Alzheimer Patients from Randomized Clinical Trials to Clinical Practice?
作者信息
Middleton L T, Touchon J, Vellas B
机构信息
Lefkos T Middleton, Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK,
出版信息
J Prev Alzheimers Dis. 2023;10(3):331-332. doi: 10.14283/jpad.2023.69.
PMID:37357264
Abstract
摘要
相似文献
1
Editorial: What Is Reasonable and Necessary for Alzheimer Patients from Randomized Clinical Trials to Clinical Practice?社论：从随机临床试验到临床实践，对阿尔茨海默病患者而言，何为合理且必要的？
J Prev Alzheimers Dis. 2023;10(3):331-332. doi: 10.14283/jpad.2023.69.
2
Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?多奈哌齐治疗与阿尔茨海默病：随机临床试验的结果能否应用于临床实践中的阿尔茨海默病患者？
Am J Geriatr Psychiatry. 2007 Nov;15(11):953-60. doi: 10.1097/JGP.0b013e3180986138.
3
Editorial: Establishing a Trial Ready Cohort to Accelerate Alzheimer's Clinical Trial Enrollment and Treatments.社论：建立一个适合试验的队列以加速阿尔茨海默病临床试验的入组和治疗
J Prev Alzheimers Dis. 2020;7(4):202-203. doi: 10.14283/jpad.2020.42.
4
Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?阿尔茨海默病及相关疾病中的神经精神症状：为何治疗在临床实践中有效但在随机试验中却无效？
Am J Geriatr Psychiatry. 2008 Jul;16(7):523-7. doi: 10.1097/JGP.0b013e318178416c.
5
Clinical drug trials in Alzheimer disease. What are some of the issues?阿尔茨海默病的临床药物试验。存在哪些问题？
Alzheimer Dis Assoc Disord. 1990 Winter;4(4):193-202. doi: 10.1097/00002093-199040400-00001.
6
Alzheimer's disease clinical trials: where are we now?阿尔茨海默病临床试验：我们目前进展如何？
Can J Neurol Sci. 2006 Feb;33(1):5. doi: 10.1017/s0317167100004637.
7
Conventional trial designs offer limited clinical understanding of cholinesterase-inhibitor treatment effects in Alzheimer disease.传统的试验设计对胆碱酯酶抑制剂治疗阿尔茨海默病的效果的临床理解有限。
Am J Geriatr Psychiatry. 2005 Feb;13(2):170; author reply 170-1. doi: 10.1176/appi.ajgp.13.2.170.
8
Primary prevention trials in Alzheimer disease.阿尔茨海默病的一级预防试验。
Neurology. 2006 Nov 14;67(9 Suppl 3):S2-5. doi: 10.1212/wnl.67.9_suppl_3.s2.
9
Fixing Alzheimer disease trials by improving process and methods.通过改进流程和方法来修复阿尔茨海默病试验。
Curr Alzheimer Res. 2010 Nov;7(7):564-5. doi: 10.2174/156720510793498995.
10
Ethical issues in placebo-controlled trials in Alzheimer disease.阿尔茨海默病安慰剂对照试验中的伦理问题。
Med J Aust. 2001 Jan 15;174(2):104-5. doi: 10.5694/j.1326-5377.2001.tb143168.x.
引用本文的文献
1
Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer's Disease. Are We Ready for the New Era?新型阿尔茨海默病血液生物标志物和疾病修饰疗法。我们是否已准备好迎接新时代？
J Prev Alzheimers Dis. 2024;11(4):897-902. doi: 10.14283/jpad.2024.83.
Zotero 插件